BIO Mid-America Draws Biotech, Pharma and Investors</a>
WASHINGTON, D.C. (September 28, 2007) – This week, 325 biotechnology executives and investors gathered at the BIO Mid-America VentureForum to learn about the 58 presenting Midwest biotech companies and participate in workshops and plenary sessions highlighting trends in the industry. The meeting was held in Milwaukee, Wis. on Sept. 24-26.
“BIO Mid-America VentureForum successfully brought together emerging biotech companies and investors to encourage greater investment in emerging new therapies for diseases,” said BIO President and CEO Jim Greenwood.
For the first time at BIO Mid-America, several of the world’s largest pharmaceutical companies, including Abbott, Eli Lilly and Company, Procter & Gamble, and Pfizer Inc, provided corporate presentations sharing business development strategies and highlighting their focus on partnerships with emerging companies. BIO added these presentations to the program because of pharmaceutical companies’ interest in reaching early stage companies, and their investors, for potential deal making.
“These presentations exemplify the growing trend of large cap pharmaceutical companies’ commitment to identifying and partnering with seed and early-stage entrepreneurial companies,” said Alan Eisenberg, executive vice president of emerging companies and business development at BIO.
The event featured presentation on biotech companies, a series of workshops on biotech trends and strategies, business development opportunities, and networking receptions. GE Healthcare’s Michael J. Barber presented a keynote address focused on GE's Early Health strategy to use technology and bio-science to transform healthcare through earlier diagnosis, information, intervention and ongoing monitoring of disease and disease indicators.
Partners for the 2007 conference include BioOhio, Colorado Bioscience Association, Illinois Biotechnology Industry Organization, Indiana Health Industry Forum, Iowa Biotechnology Association, LifeScience Alley, MichBio, Missouri Biotechnology Association, and the Wisconsin Biotechnology and Medical Device Association.
Upcoming BIO Events
BIO InvestorForum 2007
October 9-11, 2007
San Francisco, Calif.
BIO-Europe 2007 International Partnering Conference
November 12-14, 2007
Pacific Rim Summit on Industrial Biotechnology and Bioenergy
November 14-16, 2007
2008 BIO International Convention
June 17-20, 2008
San Diego, Calif.
Visit www.bio.org for information on all upcoming events.
About BIO www.bio.org
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the annual BIO International Convention, the world’s largest gathering of the biotechnology industry.
About the BIO Mid-America VentureForum http://bma.bio.org
BIO Mid-America will feature presentations from up to 60 promising seed, early- and late-stage private biotech product and platform companies from the Midwest as well as presentations from leading North American venture capital firms in the life sciences field. Workshops and plenary sessions will be offered on trends in the biotech industry, with a special focus on key success factors for early-stage companies, research and development, market trends, and financing. In addition, there will be formal and informal networking opportunities with industry CEOs and venture capital leaders.